For the "second transaction" to be approved/enacted, BIOAQ likely has to deliver unencumbered equity (w/o any liens). That would be the reason this last piece- the class action suit- needs to be cleared out of the way. At least that is the logic of the narrative, IMO.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.